Wednesday, September 30, 2020 5:58:47 PM
Market Capitalization: $1.02 Billion
On August 24, Luminar, an automotive lidar technology company, agreed to a reverse merger with Gores Metropoulos (NASDAQ:GMHI), a SPAC stock. Lidar sensors use lasers to make 3-D representations of objects. Luminar is used by 7 of the top 1o global automakers for auto self-driving technology. Also, it claims to have 50 partner companies, including Volvo which will use Luminar’s products in its 2022 vehicles.
Gores Metropolous will contribute $400 million in cash to the deal and a number of high rollers including Peter Thiel, who first funded Google, will supply an additional $170 million. The company claims the deal will have an estimated enterprise value (EV) of $2.9 billion, based on a projected market value of $3.4 billion. The stock ticker will change to “LAZR.”
Interestingly though, as of today the stock has a market cap of just $1.06 billion. So if the transaction promoter’s expectations come to pass, the stock could more than double.
However starting on page 24 of Luminar’s slide presentation, the financials show EBITDA losses up until the end of 2024. In 2024 it will make $124 million, more than doubling to $365 million by the end of 2025.
That puts the expected $2.9 billion of EV after the merger closes (assuming the stock rises over 100%), at 8 times the EBITDA of five years in the future. Assuming at least a 15% discount rate, the present value of the 2025 EBITDA is actually just half of that (49.7%). So the real EV-to-EBITDA number is actually twice the stated number, or 16 times EBITDA. That’s a little high.
9 Outbreak-Fueled Stocks to Buy This Week
Nevertheless, today’s valuation of $1.06 billion for GMHI stock is too low. It implies a paltry $500 million EV and just 1.36 times 2025 EBITDA. Even after discounting it is about 2.7 times. Therefore I believe a more appropriate price is at least twice today’s pricing. Expect to see GMHI stock (and LAZR post-merger) to double upon closing.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM